Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH

Radiotherapy and Oncology

Volumn 83, Issue 3, 2007, Pages 362-366

  Sørensen, Brita Singers ^a   Alsner, Jan ^a   Overgaard, Jens ^a   Horsman, Michael R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ca9; FaDu cells; Glut1; LDH A; LOX; OPN; Oxygen dependency; pH; SiHa cells

Indexed keywords

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; LACTATE DEHYDROGENASE; OSTEOPONTIN; OXYGEN; PROTEIN LYSINE 6 OXIDASE;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PH MEASUREMENT; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OSTEOPONTIN; OXYGEN; RNA, MESSENGER; TIME FACTORS;

EID: 34250163269     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.04.028     Document Type: Article

References (32)

1. Airley R.E., Loncaster J., Raleigh J.A., et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104 (2003) 85-91
2. Bache M., Reddemann R., Said H.M., et al. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. Int J Radiat Oncol Biol Phys 66 (2006) 1481-1487
3. Chou S.C., Azuma Y., Varia M.A., and Raleigh J.A. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. Br J Cancer 90 (2004) 728-735
4. Eriksen J.G., and Horsman M.R. Tumour hypoxia - a characteristic feature with a complex molecular background. Radiother Oncol 81 (2006) 119-121
5. Erler J.T., Bennewith K.L., Nicolau M., et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440 (2006) 1222-1226
6. Helmlinger G., Yuan F., Dellian M., and Jain R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3 (1997) 177-182
7. Hoskin P.J., Sibtain A., Daley F.M., and Wilson G.D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89 (2003) 1290-1297
8. Jonathan R.A., Wijffels K.I., Peeters W., et al. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79 (2006) 288-297
9. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
10. Koritzinsky M., Seigneuric R., Magagnin M.G., Beucken T.V., Lambin P., and Wouters B.G. The hypoxic proteome is influenced by gene-specific changes in mRNA translation. Radiother Oncol (2005)
11. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89 (2003) 877-885
12. Lal A., Peters H., St Croix B., et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93 (2001) 1337-1343
13. Le Q.T., Sutphin P.D., Raychaudhuri S., et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res 9 (2003) 59-67
14. Loncaster J.A., Harris A.L., Davidson S.E., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61 (2001) 6394-6399
15. Lukacova S., Khalil A.A., Overgaard J., Alsner J., and Horsman M.R. Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum. Int J Radiat Biol 81 (2005) 937-944
16. Lukacova S., Overgaard J., Alsner J., and Horsman M.R. Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models. Radiother Oncol 80 (2006) 165-171
17. Mekhail K., Gunaratnam L., Bonicalzi M.E., and Lee S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol 6 (2004) 642-647
18. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
19. Nordsmark M., Loncaster J., quino-Parsons C., et al. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study. Radiother Oncol 80 (2006) 123-131
20. Olive P.L., Aquino-Parsons C., MacPhail S.H., et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61 (2001) 8924-8929
21. Overgaard J., Eriksen J.G., Nordsmark M., Alsner J., and Horsman M.R. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 6 (2005) 757-764
22. Petrik D., Lavori P.W., Cao H., et al. Plasma osteopontin is an independent prognostic marker for head and neck cancers. J Clin Oncol 24 (2006) 5291-5297
23. Said H.M., Katzer A., Flentje M., and Vordermark D. Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76 (2005) 200-205
24. Sørensen B.S., Hao J., Overgaard J., et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 76 (2005) 187-193
25. Stubbs M., McSheehy P.M., Griffiths J.R., and Bashford C.L. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6 (2000) 15-19
26. Takagi H., King G.L., and Aiello L.P. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47 (1998) 1480-1488
27. Troost E.G., Bussink J., Kaanders J.H., et al. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. Radiother Oncol 76 (2005) 194-199
28. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49 (1989) 6449-6465
29. Vordermark D., Kaffer A., Riedl S., Katzer A., and Flentje M. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61 (2005) 1197-1207
30. Willam C., Warnecke C., Schefold J.C., et al. Inconsistent effects of acidosis on HIF-alpha protein and its target genes. Pflugers Arch 451 (2006) 534-543
31. Wykoff C.C., Beasley N.J., Watson P.H., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) 7075-7083
32. Xu L., and Fidler I J. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 60 (2000) 4610-4616